We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current FAB market cap is 6.72M. The company's latest EPS is GBP -0.0233 and P/E is -3.03.
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 3.9M | 4.17M | 4.8M | 2.9M | 1.14M |
Operating Income | -1.06M | -1.19M | -1.35M | -2.89M | -2.3M |
Net Income | -697k | -2.9M | -1.2M | -2.6M | -2.23M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 6.04M | 5.83M | 4.92M | 2.06M | 2.42M |
Total Liabilities | 1.23M | 1.08M | 1.23M | 939k | 627k |
Total Equity | 4.81M | 4.75M | 3.68M | 1.12M | 1.79M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -160k | -1.14M | -325k | -1.75M | -1.77M |
Investing | -103k | -362k | -257k | -111k | 1,000 |
Financing | -184k | 2.65M | -55k | 3k | 2.77M |
Market Cap | 6.72M |
Price to Earnings Ratio | -3.03 |
Price to Sales Ratio | 5.92 |
Price to Cash Ratio | 5.6 |
Price to Book Ratio | 3.75 |
Dividend Yield | - |
Shares Outstanding | 95.37M |
Average Volume (1 week) | 439.43k |
Average Volume (1 Month) | 2.68M |
52 Week Change | 65.88% |
52 Week High | 8.25 |
52 Week Low | 2.90 |
Spread (Intraday) | 0.3 (4.17%) |
Company Name | Fusion Antibodies Plc |
Address |
1 springbank road belfast BT17 0QL |
Website | https://www.fusionantibodies.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions